Atom | Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21

Due Dates: March 3, 2025 (New/Renewal/Resubmission) | October 3, 2025 (New/Renewal/Resubmission)

Funding Amounts: Up to $275,000 direct costs over 2 years (max $200,000 in any single year); estimated total program funding $3,000,000 for ~7 awards.

Summary: Supports exploratory/developmental research to advance understanding, diagnosis, and treatment of Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); clinical trials are not allowed.

Key Information: Applications must include an animal/cellular model or patient biospecimens/data; non-responsive applications will be withdrawn without review.

Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)

Sign in to see full grant listing